Find Events
or
Combination Products cGMP Final Rule <br><I>Former FDA Official Helps You Navigate the Combination Products Minefield</i>
Registration
Webinar PLUS Audio CD/Transcript - March 21, 2013 <p>
<b><i><span style="color: #ff0000">Best Value! Save $197!</span></i></b><br />
You’ll have access to one log-in and dial-in for the live 90-minute webinar for unlimited participants. You also receive all presentation materials and the opportunity to ask question by phone and email, <i>plus</i> an audio CD and transcript for the entire session.
</p>
$597.00
Webinar Only - March 21, 2013 <p>
You get one log-in and dial-in for the live 90-minute webinar for unlimited participants, presentation materials and the opportunity to ask question by phone and email.
</p>
$397.00
24/7 ENCORE Audio Presentation PLUS Audio CD/Transcript - March 21, 2013 <p>
You'll have access to one dial-in for an archived recording of the entire 90-minute webinar, including the Q&A period, <i>for unlimited participants</i>.
You can dial in any time of day or night for three weeks, from March 25 – April 12, 2013. You'll also receive all presentation materials, <i>plus</i> an audio CD and transcript for the entire session.
</p>
$597.00
24/7 ENCORE Audio Presentation - March 21, 2013 <p>
You'll have access to one dial-in for an archived recording of the entire 90-minute webinar, including the Q&A period, <i>for unlimited participants</i>.
You can dial in any time of day or night for three weeks, from March 25 – April 12, 2013. You'll also receive all presentation materials.
</p>
$397.00
Combination Products cGMP Final Rule - Webinar CD/Transcript
List Price
Our Price
Quantity
Audio CD/Transcript - March 21, 2013
$287.00
Audio CD/Transcript - March 21, 2013
$258.00
Audio CD/Transcript - March 21, 2013
$244.00
Audio CD/Transcript - March 21, 2013
$230.00
Audio CD/Transcript - March 21, 2013
$215.00
Webinar PLUS Audio CD/Transcript - March 21, 2013 <p>
<b><i><span style="color: #ff0000">Best Value! Save $197!</span></i></b><br />
You’ll have access to one log-in and dial-in for the live 90-minute webinar for unlimited participants. You also receive all presentation materials and the opportunity to ask question by phone and email, <i>plus</i> an audio CD and transcript for the entire session.
</p>
$597.00
Webinar Only - March 21, 2013 <p>
You get one log-in and dial-in for the live 90-minute webinar for unlimited participants, presentation materials and the opportunity to ask question by phone and email.
</p>
$397.00
24/7 ENCORE Audio Presentation PLUS Audio CD/Transcript - March 21, 2013 <p>
You'll have access to one dial-in for an archived recording of the entire 90-minute webinar, including the Q&A period, <i>for unlimited participants</i>.
You can dial in any time of day or night for three weeks, from March 25 – April 12, 2013. You'll also receive all presentation materials, <i>plus</i> an audio CD and transcript for the entire session.
</p>
$597.00
24/7 ENCORE Audio Presentation - March 21, 2013 <p>
You'll have access to one dial-in for an archived recording of the entire 90-minute webinar, including the Q&A period, <i>for unlimited participants</i>.
You can dial in any time of day or night for three weeks, from March 25 – April 12, 2013. You'll also receive all presentation materials.
</p>
$397.00
Combination Products cGMP Final Rule - Webinar CD/Transcript
List Price
Our Price
Quantity
Audio CD/Transcript - March 21, 2013
$287.00
Audio CD/Transcript - March 21, 2013
$258.00
Audio CD/Transcript - March 21, 2013
$244.00
Audio CD/Transcript - March 21, 2013
$230.00
Audio CD/Transcript - March 21, 2013
$215.00
When
Event Description
It doesn’t get better than this: FDAnews presents former Products Classification Officer with the FDA’s Office of Combination Products, Suzanne O’Shea, J.D., who will speak straight to the heart of your concerns in Combination Products cGMP Final Rule. Attendees will leave with a better understanding of how the FDA thinks about combination products. This understanding will enable development of better quality systems, human factors testing, and management of postapproval changes.